Tag: health
-
Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., 608 U.S. _ (2026)
The Supreme Court’s unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., 608 U.S. ___ (2026), is an important development in the continuing balance between pharmaceutical patent protection and generic drug access. The case sits at the intersection of three highly practical areas: Hatch-Waxman generic approval, Orange Book method-of-use patents, and induced infringement under…
EPIMED RESEARCH 